学术探索
学术期刊
新闻热点
数据分析
智能评审

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

被引：368
作者：
Andes, David [1 ]
Pascual, Andres [2 ,3 ]
Marchetti, Oscar [2 ,3 ]
机构：
[1] Univ Wisconsin, Sect Infect Dis & Med Microbiol & Immunol, Dept Med, Madison, WI 53792 USA
[2] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland
[3] Univ Lausanne, CH-1011 Lausanne, Switzerland
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 01期
关键词：
LIPOSOMAL AMPHOTERICIN-B; PERFORMANCE LIQUID-CHROMATOGRAPHY; MULTIPLE-DOSE PHARMACOKINETICS; ORAL SOLUTION; POPULATION PHARMACOKINETICS; INVASIVE ASPERGILLOSIS; ITRACONAZOLE THERAPY; ADVERSE EVENTS; PLASMA-LEVELS; VORICONAZOLE;
D O I：
10.1128/AAC.00705-08
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：24 / 34
页数：11
相关论文
共 103 条
[81]   HIGH-DOSE ITRACONAZOLE IN THE TREATMENT OF SEVERE MYCOSES [J].
SHARKEY, PK ;
RINALDI, MG ;
DUNN, JF ;
HARDIN, TC ;
FETCHICK, RJ ;
GRAYBILL, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :707-713
[82]   Voriconazole therapeutic drug monitoring [J].
Smith, J ;
Safdar, N ;
Knasinski, V ;
Simmons, W ;
Bhavnani, SM ;
Ambrose, PG ;
Andes, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1570-1572
[83]   TOXICITY OF AMPHOTERICIN-B PLUS FLUCYTOSINE IN 194 PATIENTS WITH CRYPTOCOCCAL MENINGITIS [J].
STAMM, AM ;
DIASIO, RB ;
DISMUKES, WE ;
SHADOMY, S ;
CLOUD, GA ;
BOWLES, CA ;
KARAM, GH ;
ESPINELINGROFF, A .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (02) :236-242
[84]   Itraconazole in cyclodextrin solution [J].
Stevens, DA .
PHARMACOTHERAPY, 1999, 19 (05) :603-611
[85]   Single- and multiple-dose pharmacokinetics of caspofungin in healthy men [J].
Stone, JA ;
Holland, SD ;
Wickersham, PJ ;
Sterrett, A ;
Schwartz, M ;
Bonfiglio, C ;
Hesney, M ;
Winchell, GA ;
Deutsch, PJ ;
Greenberg, H ;
Hunt, TL ;
Waldman, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :739-745
[86]   Therapeutic drug monitoring of systemic antifungal therapy [J].
Summers, KK ;
Hardin, TC ;
Gore, SJ ;
Graybill, JR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (06) :753-764
[87]   Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities [J].
Tan, K ;
Brayshaw, N ;
Tomaszweski, K ;
Troke, P ;
Wood, N .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (02) :235-243
[88]   Cost-effectiveness of therapeutic drug monitoring - A systematic review [J].
Touw, DJ ;
Neef, C ;
Thomson, AH ;
Vinks, AA .
THERAPEUTIC DRUG MONITORING, 2005, 27 (01) :10-17
[89]  
TRICOT G, 1987, REV INFECT DIS, V9, pS94
[90]   Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients [J].
Trifilio, S ;
Ortiz, R ;
Pennick, G ;
Verma, A ;
Pi, J ;
Stosor, V ;
Zembower, T ;
Mehta, J .
BONE MARROW TRANSPLANTATION, 2005, 35 (05) :509-513
234567891011